Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · IEX Real-Time Price · USD
1.840
+0.010 (0.55%)
At close: May 31, 2024, 4:00 PM
1.820
-0.020 (-1.09%)
After-hours: May 31, 2024, 4:10 PM EDT
Fortress Biotech Stock Forecast
FBIO's stock price has decreased by -77.2% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Fortress Biotech stock have an average target of 33.33, with a low estimate of 10 and a high estimate of 75. The average target predicts an increase of 1,711.41% from the current stock price of 1.84.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for FBIO stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +443.48% | May 16, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +443.48% | Mar 15, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $30 → $15 | Strong Buy | Maintains | $30 → $15 | +715.22% | Nov 29, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $75 | Buy | Reiterates | $75 | +3,976.09% | Aug 15, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $90 → $75 | Buy | Maintains | $90 → $75 | +3,976.09% | May 16, 2023 |
Financial Forecast
Revenue This Year
75.40M
from 84.51M
Decreased by -10.79%
Revenue Next Year
128.48M
from 75.40M
Increased by 70.41%
EPS This Year
-4.80
from -8.47
EPS Next Year
-3.27
from -4.80
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 90.9M | 141.1M | 187.2M | 119.8M |
| Avg | 75.4M | 128.5M | 171.5M | 116.4M |
| Low | 58.1M | 114.7M | 154.8M | 111.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 7.5% | 87.1% | 45.7% | -30.1% |
| Avg | -10.8% | 70.4% | 33.5% | -32.1% |
| Low | -31.2% | 52.1% | 20.5% | -34.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.43 | -2.69 | -2.10 |
| Avg | -4.80 | -3.27 | -2.91 |
| Low | -6.72 | -4.08 | -3.64 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.